Vir Biotechnology, Inc.

San Francisco, California, United States vir.bio

Overview

Vir Biotechnology, Inc. is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company is dedicated to creating solutions by utilizing various platforms, including monoclonal antibody, T cell and small interfering ribonucleic acid platforms.

Therapeutic areas

Infectious DiseasesImmunology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Vir Biotechnology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

454 Life Sciences Corporation
United States
ABC Health Research Institute
USA
AC Biotech Incorporated
USA
ADMA Biologics, Inc.
United States
Aequita Bioworks Inc.
United States
AGC Biopharma, Inc.
USA
BigHat Biosciences, Inc.
United States
Catalent, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo